Delivery Order SPE2DB22D3016-SPE2DB25FAUA2

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $19,727.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. This contract is not set aside and was awarded through open competition. Amerisourcebergen Drug...
This federal contract award, valued at $60,420.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 27, 2024. The contract is a delivery order for the supply of Nurtec ODT 75 mg tablets, a medication used for the treatment of migraines. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Nurtec ODT 75 MG Tablet 8S, a medication used for the treatment of migraines. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $69,098.39 and an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, SPE2DB22D1202|SPE2DB25FUYJ9, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $25,478.68 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of April 21, 2025 and is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $16,015.13 and a period of performance through April 18, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....
This federal contract award, valued at $20,976.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Nurtec ODT 75 mg tablets, a medication used for treating migraines. The contract has an ultimate completion date of October 14, 2021 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a separate Indefinite...
This federal contract award, valued at $21,024.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FUXEQ) under Amerisourcebergen's existing Indefinite Delivery Contract (SPE2DB25D3018) with DLA, which has a ceiling value of $999,999,999.00 and provides comprehensive global pharmaceutical support through December 2026. The current delivery order is for the supply of Nurtec ODT 75 mg...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,110.24 firm fixed-price contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of April 9, 2025 and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger $999,999,999.00...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $48,630.00 contract is for the supply of Nurtec ODT 75 mg tablets, which are used to treat migraines. The contract has a period of performance through February 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $27,277.47 and a completion date of September 20, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAUA2
    Delivery Order

This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAUA2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $30,816.53 and is a firm fixed-price delivery order, with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which has a ceiling value of $999,999,999.00 and provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026.

Generated 7/17/25, 5:51 PM